650
Participants
Start Date
October 31, 2007
Primary Completion Date
October 31, 2008
Study Completion Date
November 30, 2008
TDS-943 (topical diclofenac sodium 4% spray)
celecoxib
placebo
Brooklyn
Duncansville
Bensalem
Towson
Virginia Beach
Asheville
Charleston
Marietta
Blue Ridge
Savannah
New Smyrna Beach
Boynton Beach
Delray Beach
St. Petersburg
Sarasota
Ococee
Birmingham
Birmingham
Marion
Cleveland
Cincinnati
Kalamazoo
Milwaukee
Chicago
Kansas City
Overland Park
Omaha
Little Rock
Oklahoma City
Oklahoma City
Nederland
San Antonio
San Antonio
Austin
Denver
Boise
Phoenix
Chandler
Westlake Village
Foothill Ranch
Irvine
Anaheim
Anaheim
Danbury
Milford
Stanford
Brockton
Berlin
Medford
Lead Sponsor
Mika Pharma GmbH
INDUSTRY